These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10653432)

  • 1. Retinal vascular occlusion and deficiencies in the protein C pathway.
    Vine AK
    Am J Ophthalmol; 2000 Jan; 129(1):113-5. PubMed ID: 10653432
    [No Abstract]   [Full Text] [Related]  

  • 2. Retinal vascular occlusion and deficiencies in the protein C pathway.
    Gamel J
    Am J Ophthalmol; 2000 Jan; 129(1):112-3. PubMed ID: 10653431
    [No Abstract]   [Full Text] [Related]  

  • 3. Retinal vascular occlusion and deficiencies in the protein C pathway.
    Greiner K; Hafner G; Dick B; Peetz D; Prellwitz W; Pfeiffer N
    Am J Ophthalmol; 1999 Jul; 128(1):69-74. PubMed ID: 10482096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C resistance, factor V Leiden, and retinal vessel occlusion.
    Ma AD; Abrams CS
    Retina; 1998; 18(4):297-300. PubMed ID: 9730170
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral retinal neovascularization and retinal vascular occlusion associated with activated protein C resistance.
    Greven CM; Wall AB
    Am J Ophthalmol; 1997 Nov; 124(5):687-9. PubMed ID: 9372725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel PAX3 mutation in a Korean patient with Waardenburg syndrome type 1 and unilateral branch retinal vein and artery occlusion: a case report.
    Choi EY; Choi W; Lee CS
    BMC Ophthalmol; 2018 Oct; 18(1):266. PubMed ID: 30314436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral retinal vein occlusion associated with factor V Leiden mutation.
    Spagnolo BV; Nasrallah FP
    Retina; 1998; 18(4):377-8. PubMed ID: 9730185
    [No Abstract]   [Full Text] [Related]  

  • 8. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions.
    Glueck CJ; Ping Wang ; Hutchins R; Petersen MR; Golnik K
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):286-94. PubMed ID: 18160589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for resistance to activated protein C and the mutant gene for factor V:Q506 in patients with central retinal vein occlusion.
    Vine AK; Samama MM
    Am J Ophthalmol; 1997 Nov; 124(5):673-6. PubMed ID: 9372721
    [No Abstract]   [Full Text] [Related]  

  • 10. [Retinal vascular occlusion and polymorphisms in genes coding for components of vitamin K cycle].
    Kakhktsyan SS; Moshetova LK; Turkina KI; Sychev DA
    Vestn Oftalmol; 2016; 132(4):94-97. PubMed ID: 28635929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central retinal artery occlusion in a patient homozygous for factor V Leiden.
    Larsson J
    Am J Ophthalmol; 2000 Jun; 129(6):816-7. PubMed ID: 10927002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial vascular occlusion associated with factor V Leiden gene mutation.
    Tayyanipour R; Pulido JS; Postel EA; Lipkowitz JL; Pisciotta A; Braza E
    Retina; 1998; 18(4):376-7. PubMed ID: 9730184
    [No Abstract]   [Full Text] [Related]  

  • 13. Branch retinal arteriolar occlusion associated with familial factor V Leiden polymorphism and positive rheumatoid factor.
    Dhar-Munshi S; Ayliffe WH; Jayne D
    Arch Ophthalmol; 1999 Jul; 117(7):971-3. PubMed ID: 10408469
    [No Abstract]   [Full Text] [Related]  

  • 14. Central retinal vein thrombosis associated with resistance to activated protein C.
    Dhôte R; Bachmeyer C; Horellou MH; Toulon P; Christoforov B
    Am J Ophthalmol; 1995 Sep; 120(3):388-9. PubMed ID: 7661212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hereditary disorders of the protein C system in central artery and branch arteriolar occlusions].
    Greiner K; Hafner G; Prellwitz W; Pfeiffer N
    Klin Monbl Augenheilkd; 1999 Jul; 215(1):33-6. PubMed ID: 10448635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden mutation does not correlate with retinal vascular occlusion in white patients with Behçet's disease.
    Chen Y; Stanford MR; Wallace GR; Vaughan RW; Kondeatis E; Fortune F
    Br J Ophthalmol; 2003 Aug; 87(8):1048-9. PubMed ID: 12881356
    [No Abstract]   [Full Text] [Related]  

  • 17. [Retinal vein occlusion and resistance to activated protein C].
    Scat Y; Morin Y; Morel C; Haut J
    J Fr Ophtalmol; 1995; 18(12):758-62. PubMed ID: 8745708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent branch retinal vein occlusion with factor V leiden mutation.
    Banik S; Bhutto HU; Bagga P
    Eye (Lond); 2006 Aug; 20(8):948-9. PubMed ID: 16113634
    [No Abstract]   [Full Text] [Related]  

  • 19. Retinal arterial occlusion in a child with factor V Leiden and thermolabile methylene tetrahydrofolate reductase mutations.
    Talmon T; Scharf J; Mayer E; Lanir N; Miller B; Brenner B
    Am J Ophthalmol; 1997 Nov; 124(5):689-91. PubMed ID: 9372726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion.
    Hvarfner C; Hillarp A; Larsson J
    Br J Ophthalmol; 2003 Mar; 87(3):305-6. PubMed ID: 12598443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.